Paper38782891
The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma.
Schwarcz S and 7 others. Cell Death Discov, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma. Papers, record 38782891. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38782891
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29655782 | Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. | Biochim Biophys Acta Bioenerg | 2018 | https://conductscience.org/library/papers/29655782 | PubMed |
| 2 | 19935649 | The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. | Nat Cell Biol | 2009 | https://conductscience.org/library/papers/19935649 | PubMed |
| 3 | 27185392 | Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. | Mol Oncol | 2016 | https://conductscience.org/library/papers/27185392 | PubMed |
| 4 | 31578522 | The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. | Nature | 2019 | https://conductscience.org/library/papers/31578522 | PubMed |
| 5 | 29563853 | Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders. | Mediators Inflamm | 2018 | https://conductscience.org/library/papers/29563853 | PubMed |
| 6 | 31989830 | Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. | Antioxid Redox Signal | 2020 | https://conductscience.org/library/papers/31989830 | PubMed |
| 7 | 19762477 | Effect of bile salts on the DNA and membrane integrity of enteric bacteria. | J Med Microbiol | 2009 | https://conductscience.org/library/papers/19762477 | PubMed |
| 8 | 32034405 | The potential role of bacteria in pancreatic cancer: a systematic review. | Carcinogenesis | 2020 | https://conductscience.org/library/papers/32034405 | PubMed |
| 9 | 25591600 | Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma. | Neoplasma | 2015 | https://conductscience.org/library/papers/25591600 | PubMed |
| 10 | 17438109 | Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17438109 | PubMed |
| 11 | 21364590 | Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21364590 | PubMed |
| 12 | 24855007 | Pancreatic cancer, inflammation, and microbiome. | Cancer J | 2014 | https://conductscience.org/library/papers/24855007 | PubMed |
| 13 | 26032724 | Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/26032724 | PubMed |
| 14 | 32278036 | Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32278036 | PubMed |
| 15 | 32365188 | Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy. | Blood Adv | 2020 | https://conductscience.org/library/papers/32365188 | PubMed |
| 16 | 32243985 | LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer. | Clin Chim Acta | 2020 | https://conductscience.org/library/papers/32243985 | PubMed |
| 17 | 33328627 | Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. | Sci Rep | 2020 | https://conductscience.org/library/papers/33328627 | PubMed |
| 18 | 21994333 | Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. | Gut | 2012 | https://conductscience.org/library/papers/21994333 | PubMed |
| 19 | 25641222 | Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer. | Histopathology | 2015 | https://conductscience.org/library/papers/25641222 | PubMed |
| 20 | 26942675 | Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. | Mol Cell | 2016 | https://conductscience.org/library/papers/26942675 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857021 | A saliva-derived metabolic signature with multi-omics support for oral squamous cell carcinoma diagnosis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42857021 | PubMed |
| 42809711 | Microbial-derived exerkines as a model of drug discovery. | Am J Physiol Cell Physiol | 2026 | https://conductscience.org/library/papers/42809711 | PubMed |
| 42621827 | Gut microbiota-derived metabolites as context-dependent modulators of Nrf2 signaling in inflammation-driven carcinogenesis. | Gut Microbes | 2026 | https://conductscience.org/library/papers/42621827 | PubMed |
| 41822195 | Gut microbiota-metabolism axis in digestive tumors: Emerging targets for novel therapies (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/41822195 | PubMed |
| 41675731 | Microbial metabolites from gut bacteria as novel anti-cancer agents. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/41675731 | PubMed |
| 41373683 | Lithocholic Acid Species: Metabolism, Signaling Pathways, and Clinical Significance in Enterohepatic Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373683 | PubMed |
| 40175359 | Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40175359 | PubMed |
| 39765777 | Lithocholic Acid's Ionic Compounds as Promising Antitumor Agents: Synthesis and Evaluation of the Production of Reactive Oxygen Species (ROS) in Mitochondria. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765777 | PubMed |
| 39723238 | Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39723238 | PubMed |
| 39493325 | Anti-tumor efficacy of Calculus bovis: Suppressing liver cancer by targeting tumor-associated macrophages. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/39493325 | PubMed |
| 38999024 | Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells. | Molecules | 2024 | https://conductscience.org/library/papers/38999024 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| NOS2 | 4843 | PubTator's text mining | https://conductscience.org/library/genes/4843 | NCBI Gene |
| NR1H4 | 9971 | PubTator's text mining | https://conductscience.org/library/genes/9971 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
| VDR | 7421 | PubTator's text mining | https://conductscience.org/library/genes/7421 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38782891
GET https://conductscience.org/api/papers/v1/38782891/references?page=2